Mid Continent Capital’s Novartis NVS Stock Holding History

Mid Continent Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$27.7M	Sell	335,743 -1,987	-0.6%	-$177K	1.79%	17
2015 Q2	$29.8M	Buy	337,730 +18,459	+6%	+$1.69M	1.64%	17
2015 Q1	$28.2M	Buy	319,271 +3,543	+1%	+$314K	1.55%	19
2014 Q4	$26.2M	Sell	315,728 -880	-0.3%	-$72.9K	1.49%	18
2014 Q3	$26.7M	Buy	316,608 +558	+0.2%	+$45.1K	1.55%	20
2014 Q2	$25.6M	Sell	316,050 -810	-0.3%	-$63.7K	1.49%	19
2014 Q1	$24.1M	Buy	316,860 +22,398	+8%	+$1.63M	1.45%	19
2013 Q4	$21.2M	Sell	294,462 -18,632	-6%	-$1.3M	1.31%	20
2013 Q3	$21.5M	Buy	313,094 +27,426	+10%	+$1.81M	1.51%	17
2013 Q2	$18.1M	Buy	+285,668	New	+$18.6M	1.32%	23

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Mid Continent Capital's NVS Position: Q3 2015 in Review

Mid Continent Capital reduced its Novartis (NVS) stake by 0.59% in Q3 2015, selling an estimated $177K and leaving 335,743 shares worth $27.7M. The position accounts for 1.79% of the portfolio, ranked #17.

Mid Continent Capital first reported a position in NVS in Q2 2013 and has held it in 10 quarters since. The position peaked at $29.8M in Q2 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Mid Continent Capital held 335,743 shares of Novartis worth $27.7M as of Q3 2015.
Mid Continent Capital sold 1,987 Novartis shares in Q3 2015, an estimated $177K.
Novartis made up 1.79% of Mid Continent Capital's portfolio in Q3 2015, its #17 holding.
Mid Continent Capital first reported a position in Novartis in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's Novartis position peaked at $29.8M in Q2 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.